GCC And UAE Diabetes Devices Market Size, Share & Trends Analysis Report By Services (Devices And Wearables, Diabetes Prevention, Diabetes Researches), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 2 Business Days
GCC And UAE Diabetes Devices Market Growth & Trends
The GCC and UAE diabetes devices market size is anticipated to reach USD 4.72 billion by 2030 and is set to grow at 7.1% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Factors such as the increasing prevalence of diabetes, rapid technological advancements, and increasing awareness related to diabetes preventive care are all augmenting the market growth during the forecast period. For instance, in December 2021, Sanofi signed a contract with the Dasman Diabetes Institute and Research Center (DDI), a research institute & diabetes treatment center in Kuwait, to enhance diabetes control and prevention in the country.
Diabetes is a rapidly growing disease. Some of the highest diabetes prevalence rates in the world are found in the countries of the Gulf Cooperation Council. The increase in unhealthy living continues to lead to a more unhealthy population in the region. According to International Diabetes Federation, in 2021, there were about 0.8 million patients suffering from diabetes in Kuwait, and this number is expected to increase to 1.0 million by 2045.
Over the past few decades, diabetes-related research activity has been observed to be low in this region. However, an increase in research funding and collaborations between local & international researchers and institutes are expected to boost segment growth. For instance, in January 2022, the Saudi Health Council signed a memorandum of understanding with Sanofi, a French healthcare corporation, to collaborate on diabetes research and development.
The key market players are implementing a variety of strategies, including mergers and acquisitions, partnerships, collaborations, and expansions. For instance, in August 2022, Abbott partnered with WW International, Inc. (WeightWatchers). Through this partnership, both companies will combine the weight management program of WeightWatchers for people with diabetes with Abbott's line of FreeStyle Libre products to produce a seamless mobile experience. It will offer knowledge & insights on how to improve their diet, lower the blood sugar levels of patients, and ultimately, help consumers take back control of their health.
GCC And UAE Diabetes Devices Market Report Highlights
GCC And UAE Diabetes Devices Market Growth & Trends
The GCC and UAE diabetes devices market size is anticipated to reach USD 4.72 billion by 2030 and is set to grow at 7.1% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Factors such as the increasing prevalence of diabetes, rapid technological advancements, and increasing awareness related to diabetes preventive care are all augmenting the market growth during the forecast period. For instance, in December 2021, Sanofi signed a contract with the Dasman Diabetes Institute and Research Center (DDI), a research institute & diabetes treatment center in Kuwait, to enhance diabetes control and prevention in the country.
Diabetes is a rapidly growing disease. Some of the highest diabetes prevalence rates in the world are found in the countries of the Gulf Cooperation Council. The increase in unhealthy living continues to lead to a more unhealthy population in the region. According to International Diabetes Federation, in 2021, there were about 0.8 million patients suffering from diabetes in Kuwait, and this number is expected to increase to 1.0 million by 2045.
Over the past few decades, diabetes-related research activity has been observed to be low in this region. However, an increase in research funding and collaborations between local & international researchers and institutes are expected to boost segment growth. For instance, in January 2022, the Saudi Health Council signed a memorandum of understanding with Sanofi, a French healthcare corporation, to collaborate on diabetes research and development.
The key market players are implementing a variety of strategies, including mergers and acquisitions, partnerships, collaborations, and expansions. For instance, in August 2022, Abbott partnered with WW International, Inc. (WeightWatchers). Through this partnership, both companies will combine the weight management program of WeightWatchers for people with diabetes with Abbott's line of FreeStyle Libre products to produce a seamless mobile experience. It will offer knowledge & insights on how to improve their diet, lower the blood sugar levels of patients, and ultimately, help consumers take back control of their health.
GCC And UAE Diabetes Devices Market Report Highlights
- Based on services, the pharma, drugs & supplies segment accounted for the largest market share in 2022, owing to the growing demand for efficient medication therapies for diabetes treatment
- Based on distribution channel, the hospital pharmacies segment dominated the market in 2022 and is expected to continue dominating over the forecast period
- The online pharmacies segment is expected to grow at the fastest rate over the forecast period owing to the increasing patient awareness about online pharmacies
- Based on end-use, the hospital segment held the largest market share in 2022, owing to the adoption of advanced diabetes devices by hospitals
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Services
1.1.2. Distribution Channel
1.1.3. End-use
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. GCC AND UAE DIABETES DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Easy and efficient monitoring of blood glucose levels
3.4.1.2. Technological advancements
3.4.1.3. Increasing awareness about diabetes preventive care
3.4.2. Market Restraint Analysis
3.4.2.1. High cost of devices
3.5. GCC and UAE Diabetes Devices: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Covid-19 Impact Analysis
CHAPTER 4. GCC AND UAE DIABETES DEVICES MARKET: SEGMENT ANALYSIS, BY SERVICES, 2018 - 2030 (USD MILLION)
4.1. Definitions & Scope
4.2. Services market share analysis, 2022 & 2030
4.3. Segment Dashboard
4.4. GCC and UAE Diabetes Devices Market, by Services, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
4.5.1. Devices and Wearables
4.5.1.1. Devices and wearables estimates and forecast, 2018 to 2030 (USD Million)
4.5.2. Pharma, drugs and supplies
4.5.2.1. Pharma, drugs and supplies estimates and forecast, 2018 to 2030 (USD Million)
4.5.3. Technology platforms and products
4.5.3.1. Technology platforms and products estimates and forecast, 2018 to 2030 (USD Million)
4.5.4. Genomics and multi-omics
4.5.4.1. Genomics and multi-omics estimates and forecast, 2018 to 2030 (USD Million)
4.5.5. Diabetes prevention
4.5.5.1. Diabetes prevention estimates and forecast, 2018 to 2030 (USD Million)
4.5.6. Diabetes research
4.5.6.1. Diabetes researches estimates and forecast, 2018 to 2030 (USD Million)
4.5.7. Primary care
4.5.7.1. Primary care estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 5. GCC AND UAE DIABETES DEVICES MARKET: SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
5.1. Definitions & Scope
5.2. Distribution channel market share analysis, 2022 & 2030
5.3. Segment Dashboard
5.4. GCC and UAE Diabetes Devices Market, By distribution channel, 2018 to 2030
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospital pharmacies
5.5.1.1. Hospital pharmacies estimates and forecast, 2018 to 2030 (USD Million)
5.5.2. Retail pharmacies
5.5.2.1. Retail pharmacies estimates and forecast, 2018 to 2030 (USD Million)
5.5.3. Diabetes clinics/centers
5.5.3.1. Diabetes clinics/centers estimates and forecast, 2018 to 2030 (USD Million)
5.5.4. Online pharmacies
5.5.4.1. Online pharmacies estimates and forecast, 2018 to 2030 (USD Million)
5.5.5. Others
5.5.5.1. Others estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 6. GCC AND UAE DIABETES DEVICES MARKET: SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2022 & 2030
6.3. Segment Dashboard
6.4. GCC and UAE Diabetes Devices Market, By End-use, 2018 to 2030
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals estimates and forecast, 2018 to 2030 (USD Million)
6.5.2. Homecare
6.5.2.1. Homecare estimates and forecast, 2018 to 2030 (USD Million)
6.5.3. Diagnostic centers
6.5.3.1. Diagnostic centers estimate and forecast, 2018 to 2030 (USD Million)
CHAPTER 7. GCC AND UAE DIABETES DEVICES MARKET: REGIONAL MARKET ANALYSIS, 2018 - 2030 (USD MILLION)
7.1. Definitions & Scope
7.2. Regional Market Share Analysis, 2022 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. Regional Market Share, 2022
7.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030
7.7. Saudi Arabia
7.7.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.7.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.7.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.8. UAE
7.8.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.8.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.8.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9. Oman
7.9.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.9.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.9.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10. Qatar
7.10.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.10.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.10.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11. Kuwait
7.11.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.11.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.11.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12. Bahrain
7.12.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.12.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.12.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
CHAPTER 8. GCC AND UAE DIABETES DEVICES MARKET - COMPETITIVE ANALYSIS
8.1. Key companies profiled
8.1.1. Medtronic
8.1.1.1. Company Overview
8.1.1.2. Financial Performance
8.1.1.3. Product Benchmarking
8.1.1.4. Strategic Initiatives
8.1.2. Abbot Laboratories
8.1.2.1. Company Overview
8.1.2.2. Financial Performance
8.1.2.3. Product Benchmarking
8.1.2.4. Strategic Initiatives
8.1.3. Ascensia Diabetes Care Holdings
8.1.3.1. Company Overview
8.1.3.2. Financial Performance
8.1.3.3. Product Benchmarking
8.1.3.4. Strategic Initiatives
8.1.4. Dexcom
8.1.4.1. Company Overview
8.1.4.2. Financial Performance
8.1.4.3. Product Benchmarking
8.1.4.4. Strategic Initiatives
8.1.5. F. Hoffmann- La Roche AG
8.1.5.1. Company Overview
8.1.5.2. Financial Performance
8.1.5.3. Product Benchmarking
8.1.5.4. Strategic Initiatives
8.1.6. Sanofi
8.1.6.1. Company Overview
8.1.6.2. Financial Performance
8.1.6.3. Product Benchmarking
8.1.6.4. Strategic Initiatives
8.1.7. Novo Nordisk A/S
8.1.7.1. Company Overview
8.1.7.2. Financial Performance
8.1.7.3. Product Benchmarking
8.1.7.4. Strategic Initiatives
8.1.8. Insulet Corporation
8.1.8.1. Company Overview
8.1.8.2. Financial Performance
8.1.8.3. Product Benchmarking
8.1.8.4. Strategic Initiatives
8.1.9. Ypsomed AG
8.1.9.1. Company Overview
8.1.9.2. Financial Performance
8.1.9.3. Product Benchmarking
8.1.9.4. Strategic Initiatives
8.1.10. Eli Lily
8.1.10.1. Company Overview
8.1.10.2. Financial Performance
8.1.10.3. Product Benchmarking
8.1.10.4. Strategic Initiatives
8.1.11. Astra Zeneca
8.1.11.1. Company Overview
8.1.11.2. Financial Performance
8.1.11.3. Product Benchmarking
8.1.11.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.1.1. Services
1.1.2. Distribution Channel
1.1.3. End-use
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. GCC AND UAE DIABETES DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Easy and efficient monitoring of blood glucose levels
3.4.1.2. Technological advancements
3.4.1.3. Increasing awareness about diabetes preventive care
3.4.2. Market Restraint Analysis
3.4.2.1. High cost of devices
3.5. GCC and UAE Diabetes Devices: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Covid-19 Impact Analysis
CHAPTER 4. GCC AND UAE DIABETES DEVICES MARKET: SEGMENT ANALYSIS, BY SERVICES, 2018 - 2030 (USD MILLION)
4.1. Definitions & Scope
4.2. Services market share analysis, 2022 & 2030
4.3. Segment Dashboard
4.4. GCC and UAE Diabetes Devices Market, by Services, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
4.5.1. Devices and Wearables
4.5.1.1. Devices and wearables estimates and forecast, 2018 to 2030 (USD Million)
4.5.2. Pharma, drugs and supplies
4.5.2.1. Pharma, drugs and supplies estimates and forecast, 2018 to 2030 (USD Million)
4.5.3. Technology platforms and products
4.5.3.1. Technology platforms and products estimates and forecast, 2018 to 2030 (USD Million)
4.5.4. Genomics and multi-omics
4.5.4.1. Genomics and multi-omics estimates and forecast, 2018 to 2030 (USD Million)
4.5.5. Diabetes prevention
4.5.5.1. Diabetes prevention estimates and forecast, 2018 to 2030 (USD Million)
4.5.6. Diabetes research
4.5.6.1. Diabetes researches estimates and forecast, 2018 to 2030 (USD Million)
4.5.7. Primary care
4.5.7.1. Primary care estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 5. GCC AND UAE DIABETES DEVICES MARKET: SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
5.1. Definitions & Scope
5.2. Distribution channel market share analysis, 2022 & 2030
5.3. Segment Dashboard
5.4. GCC and UAE Diabetes Devices Market, By distribution channel, 2018 to 2030
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospital pharmacies
5.5.1.1. Hospital pharmacies estimates and forecast, 2018 to 2030 (USD Million)
5.5.2. Retail pharmacies
5.5.2.1. Retail pharmacies estimates and forecast, 2018 to 2030 (USD Million)
5.5.3. Diabetes clinics/centers
5.5.3.1. Diabetes clinics/centers estimates and forecast, 2018 to 2030 (USD Million)
5.5.4. Online pharmacies
5.5.4.1. Online pharmacies estimates and forecast, 2018 to 2030 (USD Million)
5.5.5. Others
5.5.5.1. Others estimates and forecast, 2018 to 2030 (USD Million)
CHAPTER 6. GCC AND UAE DIABETES DEVICES MARKET: SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2022 & 2030
6.3. Segment Dashboard
6.4. GCC and UAE Diabetes Devices Market, By End-use, 2018 to 2030
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals estimates and forecast, 2018 to 2030 (USD Million)
6.5.2. Homecare
6.5.2.1. Homecare estimates and forecast, 2018 to 2030 (USD Million)
6.5.3. Diagnostic centers
6.5.3.1. Diagnostic centers estimate and forecast, 2018 to 2030 (USD Million)
CHAPTER 7. GCC AND UAE DIABETES DEVICES MARKET: REGIONAL MARKET ANALYSIS, 2018 - 2030 (USD MILLION)
7.1. Definitions & Scope
7.2. Regional Market Share Analysis, 2022 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. Regional Market Share, 2022
7.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030
7.7. Saudi Arabia
7.7.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.7.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.7.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.8. UAE
7.8.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.8.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.8.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9. Oman
7.9.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.9.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.9.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10. Qatar
7.10.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.10.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.10.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11. Kuwait
7.11.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.11.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.11.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12. Bahrain
7.12.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
7.12.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
7.12.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
CHAPTER 8. GCC AND UAE DIABETES DEVICES MARKET - COMPETITIVE ANALYSIS
8.1. Key companies profiled
8.1.1. Medtronic
8.1.1.1. Company Overview
8.1.1.2. Financial Performance
8.1.1.3. Product Benchmarking
8.1.1.4. Strategic Initiatives
8.1.2. Abbot Laboratories
8.1.2.1. Company Overview
8.1.2.2. Financial Performance
8.1.2.3. Product Benchmarking
8.1.2.4. Strategic Initiatives
8.1.3. Ascensia Diabetes Care Holdings
8.1.3.1. Company Overview
8.1.3.2. Financial Performance
8.1.3.3. Product Benchmarking
8.1.3.4. Strategic Initiatives
8.1.4. Dexcom
8.1.4.1. Company Overview
8.1.4.2. Financial Performance
8.1.4.3. Product Benchmarking
8.1.4.4. Strategic Initiatives
8.1.5. F. Hoffmann- La Roche AG
8.1.5.1. Company Overview
8.1.5.2. Financial Performance
8.1.5.3. Product Benchmarking
8.1.5.4. Strategic Initiatives
8.1.6. Sanofi
8.1.6.1. Company Overview
8.1.6.2. Financial Performance
8.1.6.3. Product Benchmarking
8.1.6.4. Strategic Initiatives
8.1.7. Novo Nordisk A/S
8.1.7.1. Company Overview
8.1.7.2. Financial Performance
8.1.7.3. Product Benchmarking
8.1.7.4. Strategic Initiatives
8.1.8. Insulet Corporation
8.1.8.1. Company Overview
8.1.8.2. Financial Performance
8.1.8.3. Product Benchmarking
8.1.8.4. Strategic Initiatives
8.1.9. Ypsomed AG
8.1.9.1. Company Overview
8.1.9.2. Financial Performance
8.1.9.3. Product Benchmarking
8.1.9.4. Strategic Initiatives
8.1.10. Eli Lily
8.1.10.1. Company Overview
8.1.10.2. Financial Performance
8.1.10.3. Product Benchmarking
8.1.10.4. Strategic Initiatives
8.1.11. Astra Zeneca
8.1.11.1. Company Overview
8.1.11.2. Financial Performance
8.1.11.3. Product Benchmarking
8.1.11.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of Abbreviations
Table 2 GCC and UAE diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 3 GCC and UAE diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 4 GCC and UAE diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 5 Saudi Arabia diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 6 Saudi Arabia diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Saudi Arabia diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 8 UAE diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 9 UAE diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 UAE diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 11 Oman diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 12 Oman diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Oman diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 14 Qatar diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 15 Qatar diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Qatar diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 17 Kuwait diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 18 Kuwait diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Kuwait diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Bahrain diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 21 Bahrain diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Bahrain diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of Abbreviations
Table 2 GCC and UAE diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 3 GCC and UAE diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 4 GCC and UAE diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 5 Saudi Arabia diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 6 Saudi Arabia diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Saudi Arabia diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 8 UAE diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 9 UAE diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 UAE diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 11 Oman diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 12 Oman diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Oman diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 14 Qatar diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 15 Qatar diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Qatar diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 17 Kuwait diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 18 Kuwait diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Kuwait diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Bahrain diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 21 Bahrain diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Bahrain diabetes devices market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 GCC and UAE diabetes devices market: Market snapshot
Fig. 9 GCC and UAE diabetes devices market: Market segmentation
Fig. 10 GCC and UAE diabetes devices market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 GCC and UAE diabetes devices market driver impact
Fig. 14 GCC and UAE diabetes devices market restraint impact
Fig. 15 GCC and UAE diabetes devices market porter’s five forces analysis
Fig. 16 GCC and UAE diabetes devices market PESTEL analysis
Fig. 17 GCC and UAE diabetes devices market segment dashboard
Fig. 18 GCC and UAE diabetes devices market: services movement analysis
Fig. 19 Devices and Wearables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Pharma, drugs and supplies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Technology platforms and products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Genomics and multi-omics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Diabetes prevention market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Diabetes researches market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Primary care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 GCC and UAE diabetes devices market: Segment dashboard
Fig. 27 GCC and UAE diabetes devices market: Distribution channel movement analysis
Fig. 28 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Diabetes clinics centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Others pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 GCC and UAE diabetes devices market segment dashboard
Fig. 34 GCC and UAE diabetes devices market: End-use movement analysis
Fig. 35 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Global GCC and UAE diabetes devices market: Regional movement analysis
Fig. 39 Global GCC and UAE diabetes devices market: Country outlook and key takeaways
Fig. 40 Global market share, by country
Fig. 41 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Oman market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Qatar market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Bahrain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 GCC and UAE diabetes devices market: Market snapshot
Fig. 9 GCC and UAE diabetes devices market: Market segmentation
Fig. 10 GCC and UAE diabetes devices market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 GCC and UAE diabetes devices market driver impact
Fig. 14 GCC and UAE diabetes devices market restraint impact
Fig. 15 GCC and UAE diabetes devices market porter’s five forces analysis
Fig. 16 GCC and UAE diabetes devices market PESTEL analysis
Fig. 17 GCC and UAE diabetes devices market segment dashboard
Fig. 18 GCC and UAE diabetes devices market: services movement analysis
Fig. 19 Devices and Wearables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Pharma, drugs and supplies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Technology platforms and products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Genomics and multi-omics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Diabetes prevention market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Diabetes researches market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Primary care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 GCC and UAE diabetes devices market: Segment dashboard
Fig. 27 GCC and UAE diabetes devices market: Distribution channel movement analysis
Fig. 28 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Diabetes clinics centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Others pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 GCC and UAE diabetes devices market segment dashboard
Fig. 34 GCC and UAE diabetes devices market: End-use movement analysis
Fig. 35 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Global GCC and UAE diabetes devices market: Regional movement analysis
Fig. 39 Global GCC and UAE diabetes devices market: Country outlook and key takeaways
Fig. 40 Global market share, by country
Fig. 41 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Oman market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Qatar market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Bahrain market estimates and forecast, 2018 - 2030 (USD Million)
